4.23.2010Diabetes

33
Clinical Update in Type 2 Diabetes A Case Discussion Dr. Yancey R. Holmes, MD, FACE Ohio Valley Endocrinology

Transcript of 4.23.2010Diabetes

Page 1: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 1/33

Clinical Update in Type 2 Diabetes

• A Case Discussion

• Dr. Yancey R. Holmes, MD, FACE

• Ohio Valley Endocrinology

Page 2: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 2/33

Topics for Discussion

Glycemic Targets

Therapeutic Agents

Case Discussion

Page 3: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 3/33

Glycemic Targets

American Diabetes Association

American Association of Clinical

EndocrinologistsHbA1c

Fasting glucose

Post prandial glucoseHypoglycemia

Page 4: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 4/33

Pharmacologic Agents

Sulfonylureas and Meglitinides

Metformin

Alpha-glucosidase InhibitorsThiazolidinediones

Dipeptidyl Pepdidase-4 Inhibitors

Page 5: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 5/33

Pharmacologic Agents

Welchol

Incretin Mimetic

GLP-1 AgonistsGLP-1 AnalogsAmylin Analogs

Page 6: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 6/33

Pharmacologic Agents

Human Insulin

Regular

NPHAnalog Insulin

Rapid

BasalMix

Page 7: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 7/33

Special Considerations

Heart Disease

Renal Impairment

Liver DiseaseFrailty

Weight Gain

Page 8: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 8/33

Case Discussion

Page 9: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 9/33

Case 1

56 year old man referred by cardiologist

Diabetes diagnosed during hospitalization

for acute MI associated with pulmonary

edema

BMI 32 NYHA Class III functional status

Page 10: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 10/33

Case 1

HbA1c 8.6%

Serum creatinine 1.3

Discloses that he “ain’t takin’ no damn

shots!” 

Page 11: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 11/33

Case 1 Discussion

Drug naive patient with ischemic heart

disease and systolic dysfunction

Confrontational needle-phobe

Page 12: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 12/33

Case 1

Metformin: Will it get to goal?

Sulfonylurea: Hypoglycemia concerns?

TZD’s: Fluid retention? 

DPP-4 Inhibitors?

Page 13: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 13/33

Case 2a

42 year old woman referred by friend

Strong family history. Symptoms of post

prandial fatigue.

Currently at her highest body weight.

Exercise is infrequent

Page 14: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 14/33

Page 15: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 15/33

Case 2a

Metformin

Sulfonylurea

TZDDPP-4

Injections???

Page 16: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 16/33

Case 2b

After successful adoption of healthy lifestyle

changes and metformin she maintains

HbA1c less than 6.5% over the next three

years

She presents for follow up to discuss

options to address weight gain and diabetes

BMI 32

Page 17: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 17/33

Case 2b

9 months ago HbA1c 7.3%

Metformin was titrated to 1000 mg bid

6 months ago HbA1c 6.4%

Back on track with exercise and associated 6

pound weight loss

Page 18: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 18/33

Case 2b

3 months ago HbA1c 7.1%

Recent job change, stressed out. Feels

certain she can get back on track withoutadditional medicaiton

Now HbA1c 7.8%

Weight is up 12 pounds from last visit

Very frustrated with weight gain and

constant hunger

Page 19: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 19/33

Case 2b

Metformin titration to 2500 mg?

Addition of Sulfonylurea?

Addition of TZD?Addition of DPP-4 Inhibitor?

Addition of Basal Insulin

Addition of a GLP-1 Agent

Page 20: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 20/33

Case 3a

40 year old man currently on Metformin

and SU maximal dose

FBG 160-180

PPG 160-200

HbA1c 8.2%

BMI 27

Page 21: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 21/33

Case 3a

Addition of third oral agent?

Addition of GLP-1/Amylin

Introduction of insulin?

Human vs. Analog?

What kind of dosing regimen?

Page 22: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 22/33

Case 3b

Addition of basal insulin helped maintain

good glycemic control over the next 18

months

Now HbA1c 7.8%

FBG 100-140

PPG 180-220

Page 23: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 23/33

Case 3b

Oral agents?

Mealtime insulin

Mealtime amylin

Should anything be discontinued?

Page 24: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 24/33

Case 4a

38 year old man presents forassessment after family member testsa blood sugar of 400

He has already adopted many gooddietary changes and saw the educatorat the health department

Blood sugars range from 180-250HbA1c 9.8%

BMI 31

Page 25: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 25/33

Case 4a

Metformin with continued lifestyle

modification?

Combination agent?

Insulin?

GLP-1/Amylin?

Page 26: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 26/33

Case 4b

After 5 years of maintaining HbA1c <7% on

combination Metformin+TZD blood sugars

are elevated

HbA1c 8.2%

15 pound weight gain over past 3-6 months

Page 27: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 27/33

Case 4b

Third oral agent?

Insulin?

GLP-1/Amylin?

Page 28: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 28/33

Case 5

60 year old woman with type 2diabetes for 2 years treated with SU

HbA1c has ranged from 8.2-6.8% over

that time. Currently it is 7.5%Recent attempts to titrate SU have leadto frequent hypoglycemia, particularlywith exercise

She has been trying to exercise to stopher steady weight gain of 20 poundsover the past year

Page 29: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 29/33

Case 5

Metformin?

DPP-4?

TZD?

Insulin?

GLP-1/Amylin?

Page 30: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 30/33

Case 6

36 year old woman recently relocated to

your area presents for first visit

Diabetes diagnosed last year.

Subacute onset of symptoms with passive

15 pound weight loss

Started on Metformin and titrated to 1000

mg twice daily with good response

Page 31: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 31/33

Case 6

Over past two months she has had

recurrence of symptoms

Blood sugars frequently in the 300+ range

No change in routine

Has experienced a 25 pound passive weight

loss

HbA1c now 10.5%

Page 32: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 32/33

Case 6

Additional oral therapy?

GLP-1/Amylin?

What is her diagnosis?

Page 33: 4.23.2010Diabetes

8/13/2019 4.23.2010Diabetes

http://slidepdf.com/reader/full/4232010diabetes 33/33

Thank you